| Tap a line for its trend | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 0.00× | 2.89× | 2.07× | 0.00× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| −1.70× | −0.57× | −0.61× | −0.29× | ||
| 0.09× | 0.03× | 0.04× | 0.04× | ||
| 1.13× | 2.74× | 4.09× | 4.73× | ||
| 1.02× | 159.02× | 2.78× | 3.54× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | |
|---|---|---|---|---|---|
| Receivable Days (DSO) | 0.00 | 2.07 | 2.89 | 0.00 | |
| Working Capital Turnover | -0.29 | -0.61 | -0.57 | -1.70 | |
| Asset Turnover | 0.04 | 0.04 | 0.03 | 0.09 | |
| Cash Conversion (CFO/Net Income) | 4.73 | 4.09 | 2.74 | 1.13 | |
| CFO/EBITDA | 3.54 | 2.78 | 159.02 | 1.02 |